An original stem cell study provides insight into Klinefelter syndrome.

Published Date: 05 Apr 2023

Scientists have conducted a first-of-its-kind study in a collaboration between King Abdullah University of Science and Technology (KAUST), King Abdulaziz University, Jeddah (KAU), and King Abdulaziz University Hospital, Jeddah (KAUH).

Read Full News

Latest News

Tirzepatide Effective Despite Weight-Inducing Meds

Tirzepatide is linked to significant weight loss in adults with overweight or obesity who are taking weight-inducing medications, suggesting benefits even when these therapies are continued.

US FDA Clarifies Policies on Compounding Of GLP-1 Medicines

The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of ⁠popular GLP-1 drugs, signaling tighter limits on their production as...

Analysis Links RAI Therapy to Breast Cancer Risk

Clinicians may want to discuss radioactive iodine therapy’s potential for increasing breast cancer risk with patients undergoing hyperthyroidism treatment, researchers say.

Immunovant's Treatment for Eye Disease Fails in Late-stage Trials

Immunovant said on Thursday that its therapy failed to reduce eye bulging ⁠when tested in patients with moderate-to-severe thyroid eye disease in two late-stage...

Sugary-Drink Taxes May Not Cut Fast-Food Beverage Calories

An analysis of Taco Bell drive-through sales data finds no overall reduction in the number of calories from beverages after the implementation of taxes on sugary drinks.

FDA Data Reveal Different Risks for GLP-1s

GLP-1s are linked to a broad range of adverse events — largely gastrointestinal, metabolic, and psychological — across indications, according to analysis of FDA reporting.

Todays Updates

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients with early-episode schizophrenia, new research shows.

Oncology Care Model’s Net Losses Well Exceed Savings

But the CMS’s cancer-focused alternative payment model’s losses “mask successes” that should serve as lessons, experts say.

Todays Updates

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients with early-episode schizophrenia, new research shows.

Oncology Care Model’s Net Losses Well Exceed Savings

But the CMS’s cancer-focused alternative payment model’s losses “mask successes” that should serve as lessons, experts say.

Latest News

Tirzepatide is linked to significant weight loss in adults with overweight or obesity who are taking weight-inducing medications, suggesting benefits even when these therapies are continued.

The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of ⁠popular GLP-1 drugs, signaling tighter limits on their production as...

Clinicians may want to discuss radioactive iodine therapy’s potential for increasing breast cancer risk with patients undergoing hyperthyroidism treatment, researchers say.

Immunovant said on Thursday that its therapy failed to reduce eye bulging ⁠when tested in patients with moderate-to-severe thyroid eye disease in two late-stage...

An analysis of Taco Bell drive-through sales data finds no overall reduction in the number of calories from beverages after the implementation of taxes on sugary drinks.

GLP-1s are linked to a broad range of adverse events — largely gastrointestinal, metabolic, and psychological — across indications, according to analysis of FDA reporting.

News All Time

NICE Introduces Endometriosis Fertility Pathway

An updated NICE guideline sets out a dedicated pathway for endometriosis within wider fertility guidance.

Medtronic Gets US FDA Nod to Use Surgical System in Cranial, ENT Surgeries

Medtronic said on Friday the U.S. Food and Drug Administration has cleared its surgical system ⁠for cranial and ear, nose and throat procedures, expanding the platform...

EU Reaffirms Rejection of Rare Sleep Disorder Drug

The sleep drug failed to gain approval for nighttime disruptions in children with a rare genetic disorder affecting circadian rhythm patterns.

Experts Question Evidence for New Testosterone Advice

New federal dietary guidance includes advice on boosting testosterone levels, which clinicians say is only partially rooted in evidence.

Once- or Twice-Yearly Injection for Weight Loss?

Phase 1 data suggest that WVE-007, an investigational siRNA drug given by injection, leads to reductions in visceral fat, waist circumference, and body weight.

Do ESAs for Anemia Raise Cancer Risk in Dialysis Patients?

High doses of erythropoiesis-stimulating agents were associated with an increased risk for cancer in patients on dialysis, but the real risk attributed to these medications remains unclear.

FDA Approves First Once-Weekly Insulin for Type 2 Diabetes

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

Ontario Government Proposes New Integrated EMR System

As Ontario proposes a new connected primary care medical record system, healthcare advocates are hoping to avoid the perils of previous attempts.

US FDA Approves Novo's Insulin Injection for Type 2 Diabetes

The U.S. Food and Drug ⁠Administration has approved Novo Nordisk's insulin injection, ⁠Awiqli, to control blood sugar levels ⁠in adults ‌living with type 2 diabetes, the...

Dad’s Nicotine Use May Shape Kids’ Metabolic Health

Paternal nicotine use alters metabolism in offspring, and those changes are sex-specific, a study in mice shows.

Dementia Risk May Triple With Type 1 Diabetes

The risk for dementia is significantly higher in people with diabetes, with the greatest risk among those with type 1 disease, new research shows.

Does Eating the Same Foods Work Best for Weight Loss?

Repeating the same meals and keeping calorie intake steady produces more weight loss than eating a more varied diet among individuals living with overweight or obesity.

Elinzanetant Reduces Vasomotor Symptoms in Breast Cancer

Elinzanetant reduces the severity and frequency of hot flushes and night sweats among women with breast cancer regardless of type of endocrine treatment used.

Germany Renews Push for Sugar Tax & Energy Drinks Ban for Kids

A German push to tax sugary drinks and ban energy drinks for under-16s will be voted on by the country's assembly of regional states on Friday.

Which Factors Predict Progression From Prediabetes to T2D?

A real-world study suggests that adults with prediabetes are more likely to develop type 2 diabetes if they are aged 35-64 years vs 18-34 years or have certain comorbidities.

Preventing Deficiencies After Bariatric Surgery

After bariatric surgery, deficits in B vitamins, vitamin D, iron, and zinc are common — early detection, lifelong supplementation, and tailored monitoring are essential.

Recommended News For You

Year in Review: Chronic Lymphocytic Leukemia

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

Two medications might work better for breast cancers that are resistant to one.

Advances in "next generation" photoactive cancer therapy

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

How AI will transform mental health support for patients with breast cancer

Recommended Articles For You

Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders 

The Importance of Having a Quick and Effective Heparin Antidote  

Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role 

Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

2.

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

3.

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.

4.

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

5.

Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?

1.

Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management

2.

The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy 

3.

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy

4.

Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025

5.

Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

2.

Efficient Management of First line ALK-rearranged NSCLC - Part III

3.

Updates on the First Line Management of ALK+ NSCLC

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

5.

A New Era in Managing Cancer-Associated Thrombosis

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot